MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Focal Lower Limb Myoclonus Heralding Adult Onset Fulminant SSPE

S. Jha, S. Pendyala (Kolkata, India)

Meeting: 2025 International Congress

Keywords: Dystonia: Pathophysiology, Myoclonus: Clinical features, Myoclonus: Pathophysiology

Category: Myoclonus/Tics/Stereotypies

Objective: We report a case adult onset fulminant SSPE with focal lower limb myoclonus as the predominant presenting movement disorder.

Background: Myoclonus remains a defining clinical feature of SSPE. Although slow, periodic axial myoclonus is considered characteristic of SSPE, atypical forms of myoclonus are increasingly being recognized. We report an adult fulminant SSPE with focal lower limb myoclonus and poor anatomic-radiological correlation.

Method: Case report

Results: A 25-year-old man presented with jerky movements of the right lower limb for three months followed by rapid cognitive decline and akinetic mutism. On examination, he was in a minimally conscious state, exhibiting appendicular rigidity, upper limb dystonia (more pronounced on the right) and focal distal lower limb slow myoclonus. Magnetic resonance imaging revealed asymmetric corpus striatal involvement (right more than left). Electroencephalography (EEG) revealed generalized long-interval periodic discharges, confirming the suspicion of SSPE. Cerebrospinal fluid (CSF) revealed significantly elevated measles IgG antibodies, leading to a diagnosis of fulminant SSPE, Jabbour stage III. Supportive care and isoprinosine was initiated. However, he succumbed to the illness within one month of discharge.

Conclusion: The origin of myoclonus in SSPE remains controversial with variable cephalo-caudal or caudocephalic progression. A brainstem localization of the myoclonus in our patient was suggested by the absence of time-locked EEG correlates of the lower limb myoclonus. Moreover, the myoclonus did not generalize during the disease and showed poor radiological correlation (abnormal striatal hyperintensity ipsilateral to the myoclonus). This case highlights a novel observation of the right lower limb myoclonus superimposed on a dystonic hand.

To cite this abstract in AMA style:

S. Jha, S. Pendyala. Focal Lower Limb Myoclonus Heralding Adult Onset Fulminant SSPE [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/focal-lower-limb-myoclonus-heralding-adult-onset-fulminant-sspe/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/focal-lower-limb-myoclonus-heralding-adult-onset-fulminant-sspe/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley